Sugi Predict

Sugi Predict / Targets / HNRNPUL2

HNRNPUL2

Heterogeneous nuclear ribonucleoprotein U-like protein 2 · Q1KMD3 · HNRNPUL2 on Sugi Atlas →

0 patent compounds predicted against HNRNPUL2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to HNRNPUL2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure PHASE2COMPLETED
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors PHASE1ACTIVE_NOT_RECRUITING
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Longitudinal Study of Neurogenetic Disorders nanRECRUITING
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Identification of New FTLD Genes nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia nanNOT_YET_RECRUITING
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer nanCOMPLETED
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Amyotrophic Lateral Sclerosis (ALS) Families Project nanRECRUITING
B3 for NMD: Bench to Bedside and Back nanENROLLING_BY_INVITATION
Molecular Disease Profile of Hematological Malignancies nanUNKNOWN
Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation Study nanUNKNOWN
Brain Involvement in Myotonic Dystrophy Type I: From Functional Neuroimaging to the Impact on Quality of Life nanCOMPLETED
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS nanRECRUITING
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma nanACTIVE_NOT_RECRUITING

Related proteins — ESM-2 sequence neighbours (a HNRNPUL2 binder may also engage these)

ProteinNameSimilarity
Q00PI9 — 1.000 Q00PI9 →
Q6IMY8 — 0.997 Q6IMY8 →
Q8VEK3 — 0.997 Q8VEK3 →
HNRNPU Heterogeneous nuclear ribonucleoprotein U 0.993 landscape →
ASH2L Set1/Ash2 histone methyltransferase complex subunit ASH2 0.991 landscape →
KAT8 Histone acetyltransferase KAT8 0.989 landscape →
Q8VDM6 — 0.989 Q8VDM6 →
Q9NFU0 — 0.988 Q9NFU0 →
Q6PGC1 — 0.988 Q6PGC1 →
B4GUZ2 — 0.988 B4GUZ2 →
Q5XI06 — 0.988 Q5XI06 →
DHX29 ATP-dependent RNA helicase DHX29 0.987 landscape →
KDM1A Lysine-specific histone demethylase 1A 0.987 landscape →
P93015 — 0.987 P93015 →
Q6C710 — 0.987 Q6C710 →
BRPF3 Bromodomain and PHD finger-containing protein 3 0.987 landscape →
O77775 — 0.987 O77775 →
Q91X20 — 0.987 Q91X20 →
Q4IEV4 — 0.986 Q4IEV4 →
HNRNPUL1 Heterogeneous nuclear ribonucleoprotein U-like protein 1 0.986 landscape →
Q2T9V9 — 0.986 Q2T9V9 →
NFKB1 Nuclear factor NF-kappa-B p105 subunit 0.986 landscape →
Q966L5 — 0.986 Q966L5 →
KDM5B Lysine-specific demethylase 5B 0.986 landscape →
Q8BMD7 — 0.986 Q8BMD7 →
B3N9E4 — 0.986 B3N9E4 →
Q6P542 — 0.986 Q6P542 →
P25799 — 0.986 P25799 →
B3MJ69 — 0.986 B3MJ69 →
Q6MG08 — 0.986 Q6MG08 →